BREAKING NEWS: More unexpected new anti-cancer drug side-effects discovered after patients use Melanoma drug, vermurafenib (Zelboraf)
This is a bit disturbing...
Melanoma drug's link to other skin cancers identified
By Madonna Behen, HealthDay and USA Today
The recently approved drug vemurafenib (Zelboraf) has been hailed as a breakthrough in the treatment of melanoma, the deadliest form of skin cancer. But roughly one-quarter of patients who take the medication develop a troublesome side effect: secondary skin cancers called squamous cell carcinomas.